glp 1 drugs List of approved and pending GLP-1 medications New GLP-1 Guidelines for Type

Intestinal phase of gastric secretion', Journal of Experimental Physiology , 15,55-68

b This meta-analysis states all included studies to be of high quality

They also impact the brain, particularly the hypothalamus, the area that controls hunger, by activating appetite-suppressing neurons, she says

June 2025: The European Medicines Agencys (EMAs) safety committee concluded that NAION is a very rare potential side effect of semaglutide medicines, like Wegovy

Emerging therapeutic roles Emerging evidence suggests that GLP-1 RAs may be beneficial in the management of several conditions, including metabolic dysfunction-associated steatotic liver disease, obstructive sleep apnea, knee osteoarthritis, polycystic ovary syndrome, neurodegenerative disease, and substance use disorders (Fig